Acetylsalicylic Acid Plus Intensive Blood Pressure Treatment in Patients With Unruptured Intracranial Aneurysms — PROTECT-U  

Unruptured Intracranial Aneurysms Clinical Trial

Official title: Prospective Randomized Open-label Trial to Evaluate Risk faCTor Management in Patients With Unruptured Intracranial Aneurysms

Status Recruiting

Clinical Trial Summary

Purpose of this study is to assess the hypothesis that a strategy with acetylsalicylic acid (ASA) 100 mg/day, intensive blood pressure treatment (targeted systolic blood pressure below 120 mmHg), and a blood pressure measuring device reduces the risk of aneurysm rupture or growth compared with standard care (i.e. no ASA, blood pressure management according to standard blood pressure management, no blood pressure measuring device)

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Aneurysm
• Intracranial Aneurysm
• Unruptured Intracranial Aneurysms

• NCT number: NCT03063541
• Study type: Interventional
• Source: Universitätsmedizin Mannheim
• Contact: Nima Etminan, PD Dr. med.
• Phone: +49 621 383-2360
• Email: Nima.Etminan@umm.de
• Status: Recruiting
• Phase: Phase 3
• Start date: September 21, 2017
• Completion date: October 2022